Inventor
HART AMY C
US16 patents
⚠️ This page may combine multiple inventors who share the name “HART AMY C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US10913738B2Feb 9, 2021
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations83
US9675571B2Jun 13, 2017
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
BRISTOL MYERS SQUIBB CO6 citations73
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US9765018B2Sep 19, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO4 citations71
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US12157733B2Dec 3, 2024
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US11440913B2Sep 13, 2022
Aminoimidazopyridazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US12275721B2Apr 15, 2025
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US12172975B2Dec 24, 2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
BRISTOL MYERS SQUIBB CO0 citations52
US12084426B2Sep 10, 2024
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US11618753B2Apr 4, 2023
Aminopyrrolotriazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US10301306B2May 28, 2019
Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations40